Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Aurobindo Pharma LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:524804NSE Symbol: AUROPHARMAP/E(TTM):45.89
ISIN Demat:INE406A01037Div & Yield %:0.3EPS(TTM):32.62
Book Value(Rs):336.6022235Market Cap ( Cr.):87706.22Face Value(Rs):1
    Change Company 
( In Cr)
 Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
INCOME :      
Sales Turnover 10645.648457.0011287.1415823.6813370.7712257.89
Excise Duty0.000.000.000.000.000.00
Net Sales10645.648457.0011287.1415823.6813370.7712257.89
Other Income 670.10443.92670.99589.86388.79199.22
Stock Adjustments 116.23263.95-45.51-2.99238.67289.80
Total Income11431.979164.8711912.6216410.5513998.2312746.91
EXPENDITURE :      
Raw Materials 5964.484755.955800.747241.836819.856469.55
Power & Fuel Cost191.58167.86477.99512.34526.31505.96
Employee Cost 980.56890.531600.041735.421577.141362.77
Other Manufacturing Expenses 414.51328.42705.68925.86814.44795.13
Selling and Administration Expenses 822.21939.381009.361069.84938.36786.90
Miscellaneous Expenses 164.49148.96249.13215.57235.47218.09
Less: Pre-operative Expenses Capitalised0.000.000.000.000.000.00
Total Expenditure8537.837231.109842.9411700.8610911.5710138.40
Operating Profit2894.141933.772069.684709.693086.662608.51
Interest 182.6074.5816.9428.68243.28230.86
Gross Profit2711.541859.192052.744681.012843.382377.65
Depreciation254.58243.26415.26488.00473.33413.03
Profit Before Tax2456.961615.931637.484193.012370.051964.62
Tax598.08412.16379.701043.34492.28378.56
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax-95.26-23.34-196.9336.760.8956.33
Reported Net Profit1954.141227.111454.713112.911876.881529.73
Extraordinary Items 1.179.94-81.27-0.13-1.90-8.01
Adjusted Net Profit1952.971217.171535.983113.041878.781537.74
Adjst. below Net Profit -1.698.281.69-6.42-44.880.00
P & L Balance brought forward16660.0815864.1414671.4111799.3010143.088790.74
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 263.66439.45263.67234.38175.78160.34
P & L Balance carried down18348.8716660.0815864.1414671.4111799.3010160.13
Dividend263.66439.450.000.000.00146.48
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %450.00750.00900.00400.00300.00250.00
Earnings Per Share-Unit Curr33.3520.9424.8353.1332.0326.11
Earnings Per Share(Adj)-Unit Curr33.3520.9424.8353.1332.0326.11
Book Value-Unit Curr336.62307.80292.15271.80222.78193.73